The diagnostic validity of non-invasive pancreatic function tests - A meta-analysis;Die diagnostische validität nichtinvasiver pankreasfunktionstests - Eine metaanalyse

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 10, 2004, Pages 1117-1128

  Siegmund, E ^a   Lohr J M ^b   Schuff Werner, Peter ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

Amino acid consumption test; Breath tests; Diagnostic sensitivity; Diagnostic specificity; Fecal chymotrypsin; Fecal elastase 1; Fecal fat; Pancreatic function; Pancreolauryl test; Peptide PABA test

Indexed keywords

CHYMOTRYPSIN; ELASTASE; FECES LIPID;

ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FECES ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NON INVASIVE MEASUREMENT; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS FUNCTION TEST; PANCREOLAURYL TEST;

EXOCRINE PANCREATIC INSUFFICIENCY; HUMANS; PANCREATIC FUNCTION TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 8444251383     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813604     Document Type: Article

References (98)

1. Malfertheiner P, Büchler M. Correlation of imaging and function in chronic pancreatitis. Radiol Clin North Am 1989; 27: 51-64
2. Lankisch PG, Seidensticker F, Otto J et al. Secretin-pancreozymin test (SPT) and endoscopic retrograde cholangiopancreatography (ERCP): Both are necessary for diagnosing or excluding chronic pancreatitis. Pancreas 1996; 12: 149-152
3. Clain JE, Pearson RK. Diagnosis of chronic pancreatitis. Is a gold standard necessary? Surg Clin North Am 1999; 79: 829-845
4. Glasbrenner B, Kahl S, Malfertheiner P, Modern diagnostics of chronic pancreatitis. Eur J Gastroenterol Hepatol 2002; 14: 935-941
5. Gullo L, Costa PL, Fontana G et al. Investigation of exocrine pancreatic function by continuous infusion of caerulein and secretin in normal subjects and in chronic pancreatitis. Digestion 1976; 14; 97-107
6. DiMagno EP, Layer P, Clain JE. Chronic pancreatitis. In: Go VLW, DiMagno EP, Gardner JD et al (eds). The Pancreas: Biology, Pathology, and Disease. New York: Raven Press, 1993: 665-706
7. Malfertheiner P, Glasbrenner B, Exokrine Pankreasfunktionstests. In: Mössner J, Adler G, Fölsch UR et al (eds). Erkrankungen des exkretorischen Pankreas. Jena, Stuttgart: Gustav Fischer Verlag, 1995: 147-159
8. Löser C, Fölsch UR, Diagnostik der chronischen Pankreatitis. Dtsch Med Wschr 1996; 121: 243-247
9. Liebe S, Weber J, Siegmund E et al. Untersuchungen an reinem menschlichen Pankreassekret. Methodische Aspekte der Sekretentnahme und Befundinterpretation. Dtsch Z Verdau Stoffwechselkr 1986; 46: 45-52
10. Rogos R, Appelt G, Schulze B. Simultane Registrierung von Pankreassekretionsprofilen während der endoskopischen Sekretentnahme bei Patienten mit und ohne Pankreaserkrankungen. Z Gesamte Inn Med 1987; 42: 696-699
11. Liebe S, Siegmund E, Rehpenning W. Veränderungen im reinen menschlichen Pankreassaft bei chronischer Pankreatitis. Gastroenterol J 1990; 50: 129-134
12. Weber H, Dummler W, Liebe S. Untersuchungen zur exkretorischen Pankreasfunktion. Sekretion von Eiweiß, Kalzium und Zitrat bei pankreasgesunden Probanden und Patienten mit chronischer Pankreatitis. Z Gastroenterol 1993; 31: 592-599
13. Ochi K, Harada H, Mizushima T et al. Intraductal secretin test is as useful as duodenal secretin test in assessing exocrine pancreatic function. Dig Dis Sci 1997; 42: 492-496
14. Wada K, Yamadera K, Yokoyama K et al. Application of pure pancreatic juice collection to the pancreatic exocrine function test. Pancreas 1998; 16: 124-128
15. Chowdhury RS, Forsmark CE. Review article: pancreatic function testing. Aliment Pharmacol Ther 2003; 17: 733-750
16. Committee of the Japanese Society of Gastroenterology. Final report of the committee for the standardization of secretin test. J Jpn Soc Gastroenterol 1987; 84: 1920-1924
17. Ochi K, Mizushima T, Harada H et al. Chronic pancreatitis: Functional testing. Pancreas 1998; 16: 343-348
18. Boeck WG, Adler G, Gress TM. Pancreatic function tests: When to choose, what to use. Curr Gastroenterol Rep 2001; 3: 95-100
19. Pezzilli R, Talamini G, Gullo L, Behaviour of serum pancreatic enzymes in chronic pancreatitis. Dig Liver Dis 2000; 32: 233-237
20. Domschke S, Heptner G, Kolb S et al. Decrease in plasma amino acid level after secretin and pancreozymin as an indicator of exocrine pancreatic function. Gastroenterology 1986; 90: 1031-1038
21. Heptner G, Domschke S, Schneider MU et al. Aminosäurespiegel im Plasma - dargestellt als Amino-Stickstoff - reagieren auf Stimulation des exokrinen Pankreas: Ansätze für einen Pankreasfunktionstest. Klin Wochenschr 1987; 65: 1054-1061
22. Gullo L, Pezzilli R, Ventrucci M et al. Caerulein-induced plasma amino acid decrease: a simple, sensitive, and specific test of pancreatic function. Gut 1990; 31: 926-929
23. Kemmer TP, Malfertheiner P, Häberle H et al. Die diagnostische Wertigkeit des Aminosäurenabsorptionstests beim Nachweis einer exokrinen Pankreasfunktionsstörung. Z Gastroenterol 1992; 30: 391-396
24. Löhr M, Hahn EG, Heptner G. Kommentar zum Beitrag "Die diagnostische Wertigkeit des Aminosäurenabsorptionstests beim Nachweis einer exokrinen Pankreasfunktionsstörung" von Kemmer et al. Z Gastroenterol 1993; 31: 163-164
25. Nelson DK, Maringhini A, DiMagno EP. Kommentar zum Beitrag "Die diagnostische Wertigkeit des Aminosäurenabsorptionstests beim Nachweis einer exokrinen Pankreasfunktionsstörung" von Kemmer et al. Z Gastroenterol 1994; 32: 367
26. Maringhini A, Nelson DK, Jones JD et al. Is the plasma amino acid consumption test an accurate test of exocrine pancreatic insufficiency? Gastroenterology 1994; 106: 488-493
27. Domschke W, Domschke S. Plasma amino acid consumption test. Gastroenterology 1994; 107: 1910-1911
28. Lembcke B, Konle O, Duan LP et al. Lack of accuracy of plasma alpha-amino nitrogen profiles as an indicator of exocrine pancreatic function both after continuous and bolus stimulation of the pancreas with secretin and cholecystokinin-pancreozymin. Z Gastroenterol 1994; 32: 679-683
29. Borovicka J, Schwizer W, Remy B et al. Cerulein-induced changes in plasma amino acid concentrations are not a valid test for pancreatic insufficiency. Am J Gastroenterol 1995; 90: 1111-1115
30. Gullo L, Pezzilli R, Ventrucci M. Diagnostic value of the amino acid consumption test in pancreatic diseases. Pancreas 1996; 12: 64-67
31. Mariani A, Mezzi G, Masci E et al. Accuracy of the plasma amino acid consumption test in detecting pancreatic diseases is due to different methods. Pancreas 1999; 18: 203-211
32. Wettstein M, Häussinger D, Secretin-induced plasma bicarbonate decrease as a simple indicator of exocrine pancreatic function. Pancreas 1996; 13: 193-197
33. Hennig R, Kekis PB, Friess H et al. Pancreatic polypeptide in pancreatitis. Peptides 2002; 23: 331-338
34. Egger M, Smith GD, Phillips AN. Meta-analysis: Principles and procedures. BMJ 1997; 315: 1533-1537
35. DiMagno EP, Go VLW, Summerskill WHJ. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288: 813-815
36. Lankisch PG, Schreiber A, Otto J, Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Dig Dis Sci 1983; 28: 490-493
37. Haverback BJ, Dyce BJ, Gutenberg PJ et al. Measurement of trypsin and chymotrypsin in stool. Gastroenterology 1963; 44: 588-597
38. Münch R, Bestimmung von Pankreas-Enzymen im Stuhl. Methoden, Probleme und klinische Bedeutung. Stuttgart, New York: Thierne Verlag, 1991
39. Ammann RW, Akovbiantz A, Hacki W et al. Diagnostic value of the fecal chymotrypsin test in pancreatic insufficiency, particularly chronic pancreatitis: correlation with the pancreozymin-secretin test, fecal fat excretion and final clinical diagnosis. Digestion 1981; 21: 281-289
40. Stock KP, Schenk J, Schmack B et al. Funktions - "Screening" des exokrinen Pankreas. Dtsch Med Wochenschr 1981; 106: 983-987
41. Kaspar P, Moeller G, Wahlefeld AW et al. A new photometric method for the determination of chymotrypsin in stool. Fresenius Z Anal Chem 1982; 311: 391-392
42. Dockter G, Hoppe-Seyler F, Appel W et al. Determination of chymotrypsin in stool by a new photometric method. Clin Biochem 1986; 19: 329-332
43. Ehrhardt-Schmelzer S, Otto J, Schlaeger R et al. Faecal chymotrypsin for investigation of exocrine pancreatic function: a comparison of two newly developed tests with the titrimetric method. Z Gastroenterol 1984; 22: 647-651
44. Girella E, Faggionato P, Benetazzo D et al. The assay of chymotrypsin in stool as a simple and effective test of exocrine pancreatic activity in cystic fibrosis. Pancreas 1988; 3: 254-262
45. Malecka-Panas E, Juszynski A, Chrzastek J et al. Comparison of three indirect pancreatic function tests in severe chronic pancreatitis-personal observations. Pol Arch Med Wewn 1995; 94: 315-323
46. Löser C, Möllgaard A, Fölsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996; 39: 580-586
47. Katschinski M, Schirra J, Bross A et al. Duodenal secretion and fecal excretion of pancreatic elastase-1 in healthy humans and patients with chronic pancreatitis. Pancreas 1997; 15: 191-200
48. Kitagawa M, Naruse S, Ishiguro H et al. Evaluating exocrine function tests for diagnosing chronic pancreatitis. Pancreas 1997; 15: 402-408
49. Stein J, Spirchez Z, Lembcke B et al. Untersuchungen zur Bedeutung der Elastase-Bestimmung als einen neuen nichtinvasiven Test der exokrinen Pankreasinsuffizienz. Z Gastroenterol 1997; Suppl. 1: 122-129
50. Lankisch PG, Schmidt I, König H et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998; 42: 551-554
51. Löser C, Brauer C, Aygen S et al. Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol 1998; 33: 327-334
52. Kataoka K, Hosoda M, Yasuda H et al. Assessment of exocrine pancreatic dysfunction in chronic pancreatitis. Digestion 1999; 60 (Suppl 1): 86-92
53. Carroccio A, Verghi F, Santini B et al. Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology. Dig Dis Sci 2001; 46: 1335-1342
54. Lüth S, Teyssen S, Forssmann K et al. Fecal elastase-1 determination: "Gold standard" of indirect pancreatic function tests? Scand J Gastroenterol 2001; 36: 1092-1099
55. Goldberg DM. Proteases in the evaluation of pancreatic function and pancreatic disease. Clin Chim Acta 2000; 291: 201-221
56. Gyr K, Schiffmann I, Fehr C et al. Erste Erfahrungen mit einem neuen, oralen Pankreasfunktionstest beim Menschen unter besonderer Berü cksichtigung der Magenentleerung. Schweiz Med Wochenschr 1975; 105: 1717-1718
57. Lankisch PG, Lembcke B, Indirect pancreatic function tests: Chemical and radioisotope methods. Clin Gastroenterol 1984; 13: 717-737
58. Lankisch PG, Brauneis J, Otto J et al. Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency? Gastroenterology 1986; 90: 350-354
59. Turecka-Kulesza E, Dlugosz J, Gabryelewicz A. Diagnostic value of NBT-PABA test in chronic pancreatitis. Pol Arch Med Wewn 1990; 34: 363-369
60. Cavallini G, Piubello W, Brocco G et al. Serum PABA and fluorescein in the course of Bz-Ty-PABA and pancreolauryl test as an index of exocrine pancreatic insufficiency. Dig Dis Sci 1985; 30: 655-663
61. Ventrucci M, Gullo L, Daniele P et al. Pancreolauryl test for pancreatic exocrine insufficiency. Am J Gastroenterol 1983; 78: 806-809
62. Homma T, Harada H, Koizumi M et al. Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society. Pancreas 1997; 15: 14-15
63. Kaffarnik H, Meyer-Bertenrath JG. Zur Methodik und klinischen Bedeutung eines neuen Pankreaslipase-Tests mit Fluoresceindilaurinsäureester. Klin Wochenschr 1969; 47: 221-223
64. Dominguez-Munoz JE, Malfertheiner P. Optimized serum pancreolauryl test for differentiating patients with and without chronic pancreatitis. Clin Chem 1998; 44: 869-875
65. Malfertheiner P, Büchler M, Müller A et al. Influence of extrapancreatic digestive disorders on the indirect pancreatic function test with fluorescein dilaurate. Clin Physiol Biochem 1985; 3: 166-173
66. Malfertheiner P, Büchler M, Müller A et al. Fluorescein dilaurate serum test: A rapid tubeless pancreatic function test. Pancreas 1987; 2: 53-60
67. Leodolter A, Kahl S, Dominguez-Munoz JE et al. Comparison of two tubeless function tests in the assessment of mild-to-moderate exocrine pancreatic insufficiency. Eur J Gastroenterol Hepatol 2000; 12: 1335-1338
68. Freise J, Ranft U, Fricke K et al. Chronische Pankreatitis: Sensitivität, Spezifität und prädiktiver Wert des Pankreolauryltests. Z Gastroenterol 1984; 22: 705-712
69. Pap A, Berger Z, Varro V. Tubeless pancreatic function tests used in combination for screening of pancreatic disease. Acta Med Hung 1986; 43: 39-43
70. Terbrack HG, Gürtler KH, Hüls G et al. Humanspezifische fàkale Pankreaselastase bei Kindern. Monatsschr Kinderheilkd 1996; 144: 901-905
71. Gullo L, Graziano L, Babbini S et al. Faecal elastase 1 in children with cystic fibrosis. Eur J Pediatr 1997; 156: 770-772
72. Phillips IJ, Rowe DJ, Dewar P et al. Faecal elastase 1: a marker of exocrine pancreatic insufficiency in cystic fibrosis. Ann Clin Biochem 1999; 36: 739-742
73. Cade A, Walters MP, McGinley N et al. Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis. Pediatr Pulmonol 2000; 29; 172-176
74. Walkowiak J, Herzig KH, Strzykala K et al. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 2002; 110; e7
75. Fischer B, Hoh S, Wehler M et al. Faecal elastase-1: Lyophilization of stool samples prevents false low results in diarrhoea. Scand J Gastroenterol 2001; 36: 771-774
76. Hardt PD, Hauenschild A, Nalop J et al. The commercially available ELISA for pancreatic elastase 1 based on polyclonal antibodies does measure an as yet unknown antigen different from purified elastase 1. Binding studies and clinical use in patients with exocrine pancreatic insufficiency. Z Gastroenterol 2003; 41: 903-906
77. Glasbrenner B, Schön A, Klatt S et al. Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis. Eur J Gastroenterol Hepatol 1996; 8: 1117-1120
78. Dominguez-Munoz JE, Hieronymus C, Sauerbruch T et al. Fecal elastase test: Evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol 1995; 90: 1834-1837
79. Gullo L, Ventrucci M, Tomassetti P et al. Fecal elastase 1 determination in chronic pancreatitis. Dig Dis Sci 1999; 44: 210-213
80. Gunkel U, Bitterlich N, Keim V. Value of combinations of pancreatic function tests to predict mild or moderate chronic pancreatitis. Z Gastroenterol 2001; 39: 207-211
81. Löser C, Möllgaard A, Aygen S et al. 13C-starch breath test-comparative clinical evaluation of an indirect pancreatic function test. Z Gastroenterol 1997; 35: 187-194
82. Stein J, Jung M, Sziegoleit A et al. Immunoreactive elastase 1: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem 1996; 42: 222-226
83. Amann ST, Bishop M, Curington C et al. Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis. Pancreas 1996; 13: 226-230
84. Soldan W, Henker J, Sprössig C. Sensitivity and specificity of quantitative determination of pancreatic elastase 1 in feces of children. J Pediatr Gastroenterol Nutr 1997; 24: 53-55
85. Czako L, Takacs T, Farkas G et al. Diagnostic value of fecal elastase test in pancreatic exocrine deficiency. Orv Hetil 1999; 140: 1887-1890
86. Walkowiak J, Cichy WK, Herzig KH. Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis. Scand J Gastroenterol 1999; 34: 202-207
87. Swart GR, van den Berg JWO. 13C breath tests in gastroenterological practice. Scand J Gastroenterol 1998; 33 (Suppl 225): 13-18
88. Lembcke B, Braden B, Caspary WF. Exocrine pancreatic insufficiency: accuracy and clinical value of the uniformly labelled 13C-Hiolein breath test. Gut 1996; 39: 668-674
89. Vantrappen GR, Rutgeerts PJ, Ghoos YF et al. Mixed triglyceride breath test: A noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology 1989; 96: 1126-1134
90. Ventrucci M, Cipolla A, Ubalducci GM et al. 13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency. Gut 1998; 42: 81-87
91. Evenepoel P, Hiele M, Geypens B et al. Egg protein digestion in normal subjects studied with a 13CO2 breath test. Gastroenterology 1997; 110: A 800
92. Perri F, Andriulli A. "Mixed" triglyceride breath test: methodological problems and clinical applications. Rev Med Univ Navarra 1998; 42: 99-103
93. Perri F, Clmente R, Festa V et al. Pancreatic exocrine function tests. Scand J Gastroenterol (Correspondence) 1998; 33: 1118-1120
94. DiMagno. A perspective on the use of tubeless pancreatic function tests in diagnosis. Gut 1998; 43: 2-3
95. Lankisch PG, Schmidt I. Exocrine pancreatic function tests, 1999: Is the best we have good enough. Scand J Gastroenterol 1999; 34: 945-947
96. Borowitz D. Evidence for the diagnosis of pancreatic insufficiency. Pediatr Pulmonol 2000; 29: 167-168
97. Lankisch PG. Now that fecal elastase is available in the United States, should clinicians start using it? Curr Gastroenterol Rep 2004; 6: 126-131
98. Löhr M, Schneider HT. Exokrine Pankreasinsuffizienz. Bremen: Uni Med Verlag, 2000